Serge Saxonov Insider Trades & Stock Holdings

Chief Executive Officer · 10x Genomics, Inc. · Latest filing Jun 22, 2026

Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. has 1 Form 4 trade on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.03M), net -$1.03M. Latest filing: disposed of 30K shares of $TXG on Jun 22, 2026 at $34.44.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.03M

Net open-market

-$1.03M

Latest filing

Jun 22, 2026

All insider trades by Serge Saxonov

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 22, 2026	$TXG	Sell (Open-market sale) 10b5-1	30K	$34.44	$1.03M			+12.8%	+42.8%		Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Serge Saxonov traded

• $TXG

Frequently asked questions

Has Serge Saxonov been buying or selling stock?

Serge Saxonov has 0 open-market purchases and 1 open-market sale on file, net -$1.03M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Serge Saxonov's latest insider trade?

disposed of 30K shares of $TXG on Jun 22, 2026 at $34.44.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.